About: Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis
Creator	Gomez-Pinedo, Ulises Hospital, Chi Al, Abraham Bijak Buana, Ranbebasa Chang, Tzu-Pu Huang, Han-Wei Li, Taiwan Nunsio, Patrick Ongko Wijaya, Vincent Pinzon, Rizaldy Tsai, -Kai Tzu, Taichung Wijaya, Vincent
topic	covid:fcd62ad2111efd13df467482658467125b91af85#this
source	Medline; PMC
abstract	Importance: Coronavirus disease 2019 (COVID-19) is a newly emerging infectious disease that has caused a global pandemic. The presenting symptoms are mainly respiratory symptom, yet studies have reported nervous system involvement in the disease. A systematic review and meta-analysis of these studies are required to understanding the neurologic characteristic of the disease and help physicians with early diagnosis and management. Objective: To conduct a systematic review and meta-analysis on the neurologic characteristics in patients with COVID-19. Evidence Review: Authors conducted a literature search through PubMed from January 1st, 2020 to April 8th, 2020. Furthermore, the authors added additional sources by reviewing related references. Studies presenting the neurologic features of COVID-19 patients in their data were included. Case reports and case series were also included in this review. The quality of the studies was assessed based on the Oxford Center for Evidence-Based Medicine guidelines. Selected studies were included in the meta-analysis of proportion and the heterogeneity test. Finding: From 280 identified studies, 33 were eligible, with 7,559 participants included. Most of the included studies were from China (29 [88%]). Muscle injury or myalgia was the most common (19.2%, 95%CI 15.4–23.2%) neurologic symptom of COVID-19, followed by headache (10.9%, 95%CI 8.62–13.51%); dizziness (8.7%, 95%CI 5.02–13.43%); nausea with or without vomiting (4.6%, 95%CI 3.17–6.27%); concurrent cerebrovascular disease (4.4%, 95%CI 1.92–7.91%); and impaired consciousness (3.8%, 95%CI 0.16–12.04%). Underlying cerebrovascular disease was found in 8.5% (95%CI 4.5–13.5%) of the studies. Conclusion: Neurologic findings vary from non-specific to specific symptoms in COVID-19 patients. Some severe symptoms or diseases can present in the later stage of the disease. Physicians should be aware of the presence of neurologic signs and symptoms as a chief complaint of COVID-19, in order to improve management and prevent a worsening outcome of the patients.
has issue date	2020-05-29(xsd:dateTime)
bibo:doi	10.3389/fneur.2020.00565
bibo:pmid	32574250
has license	cc-by
sha1sum (hex)	fcd62ad2111efd13df467482658467125b91af85
schema:url	https://doi.org/10.3389/fneur.2020.00565
resource representing a document's title	Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis
has PubMed Central identifier	PMC7273516
has PubMed identifier	32574250
schema:publication	Front Neurol
resource representing a document's body	covid:fcd62ad2111efd13df467482658467125b91af85#body_text
is http://vocab.deri.ie/void#inDataset of	proxy:http/ns.inria.fr/covid19/fcd62ad2111efd13df467482658467125b91af85
is schema:about of	named entity 'Coronavirus disease 2019' named entity 'Neurologic' named entity '2019' named entity 'NEWLY' covid:arg/fcd62ad2111efd13df467482658467125b91af85 named entity 'disease' named entity 'respiratory symptom' named entity 'global pandemic' named entity 'emerging infectious disease' named entity 'Neurologic' named entity 'SYSTEMATIC REVIEW' named entity 'virus to enter' named entity 'white blood cell counts' named entity 'seizures' named entity 'stroke' named entity 'altered consciousness' named entity 'myalgia' named entity 'CVD' named entity 'serum' named entity 'forest plot' named entity 'hypoxia' named entity 'muscle damage' named entity 'case reports' named entity 'blood circulation' named entity 'neuromuscular disorders' named entity 'skeletal muscle' named entity 'COVID-19' named entity 'areflexia' named entity 'neurologic manifestations' named entity 'COVID-19' named entity 'cerebrovascular events' named entity 'CVD' named entity 'CNS' named entity 'CVD' named entity 'muscle pain' named entity 'vomiting' named entity 'infection' named entity 'viral infection' named entity 'convulsion' named entity 'pneumonia' named entity 'cough' named entity 'meta-analysis' named entity 'COVID' named entity '3.5' named entity 'PNS' named entity 'neurologic' named entity 'myopathy' named entity '13.5' named entity 'hyposmia' named entity 'symptom' named entity 'case report' named entity 'muscle injury' named entity 'COVID-19' named entity 'Nausea' named entity 'peripheral nervous' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'neurological symptoms' named entity 'receptor' named entity 'ischemia' named entity 'COVID' named entity 'MERS-CoV' named entity 'observational studies' named entity 'ACE-2' named entity 'COVID-19' named entity 'hematogenous' named entity 'magnetic resonance imaging'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software